Clinical trial
Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary…
NCT00440245 · University of Saskatchewan, Other · Completed
Key facts
| NCT number | NCT00440245 |
|---|---|
| Title | Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease |
| Official title | Bronchoprotection of Salbutamol in Asthma and COPD |
| Lead sponsor | University of Saskatchewan, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma, COPD |
| Intervention type | Drug |
| Interventions | salbutamol |
| Enrollment | 28 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Feb 26, 2007 |
| Last update posted | Mar 27, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: